MTF Stock Pick Buy GlaxoSmithKline Pharmaceuticals Ltd For Target Rs. 1850 - HDFC Securities
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/07/f90fce6748f3ba93464312ae484ad48f.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
MTF Stock Pick Buy GlaxoSmithKline Pharmaceuticals Ltd For Target Rs. 1850 - HDFC Securities
TECHNICAL OBSERVATIONS
* The attached daily timeframe chart of GLAXO, which is making higher top higher bottom formation with higher volumes suggesting bullish indication for the stock.
* The stock has also breached above downward sloping trend line.
* We observe a formation of bullish pattern on daily and weekly time frame.
* The stock is trading above 21 EMA and crossed above its earlier intermediate high.
* Momentum oscillators like RSI and MACD are giving bullish indication suggesting bullish movement for the stock for few more weeks.
* The overall chart pattern of GLAXO indicates long trading opportunity. One may look to create positional long as per the levels mentioned above.
Buy GlaxoSmithKline Pharmaceuticals Ltd Up to 3 Months @ Add on dips 1580 CMP 1648.50 TGT 1850 SL 1548
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at https://www.hdfcsec.com/article/disclaimer-1795
SEBI Registration number is INZ000171337
Above views are of the author and not of the website kindly read disclaimer
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)